Brind.

Vaxcyte Inc. was listed on Nasdaq and received analyst ratings from Jefferies Financial Group on June 26, 2026.

10 reports, 4 independent Updated Wed 00:00
Still developing Reached 2 outlets in its first 24 hours
Reports
10
Developments
3
Repetition
70%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Well supportedReported by 4 independent outlets

Vaxcyte Inc. was listed on Nasdaq and received analyst ratings from Jefferies Financial Group on June 26, 2026.

Who's involved

What this event is mainly about

How it developed

Newest first. Tap a step to see who reported it.
  1. Cantor Fitzgerald reiterated an overweight rating for Vaxcyte.1 source
  2. BofA reduced its holding and Norges Bank increased its stake in Vaxcyte.1 source
  3. Vaxcyte listed on Nasdaq and received analyst ratings from Jefferies.1 source

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped
6 more outlets ran the same wire story